Home/Filings/4/0001127602-24-004462
4//SEC Filing

Granowitz Craig B 4

Accession 0001127602-24-004462

CIK 0001062822other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:14 PM ET

Size

7.8 KB

Accession

0001127602-24-004462

Insider Transaction Report

Form 4
Period: 2024-02-08
Granowitz Craig B
SVP, Chief Medical Officer
Transactions
  • Award

    Restricted Stock Units

    2024-02-08+222,680222,680 total
    Common Stock (222,680 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-02-08+222,680222,680 total
    Exercise: $2.15Exp: 2034-02-08Common Stock (222,680 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
  • [F3]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.

Issuer

LEXICON PHARMACEUTICALS, INC.

CIK 0001062822

Entity typeother

Related Parties

1
  • filerCIK 0001876655

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:14 PM ET
Size
7.8 KB